U.S., April 5 -- ClinicalTrials.gov registry received information related to the study (NCT06910111) titled 'CAPTURE Study (Polyglucosamine for Cardio & Atherosclerosis Prevention and Treatment Via Fat Uptake REduction)' on Feb. 27.
Brief Summary: This clinical investigation is intended to confirm the application of a new intended purpose and a new indication for an already certified medical device. Therefore, it is a pivotal clinical investigation with a confirmatory type of design.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Atherosclerotic Disease
Intervention:
DEVICE: Polyglucosamine
The treatment will continue for 12 months administering a customized Polyglucosamine (formoline AtheroGuard) (twice/day) befor...